Thrombophilia risks have not been found to contribute to the CTEPH pathobiology, but there are data indicating a more central role of vWF, including interaction with the inflammatory pathway [29,30,31,32,33]. This evidence concerns the gene VWF and chronic thromboembolic pulmonary hypertension.